Mastery EAQ Ch. 12

A  0.2 mg (2 mL) intravenously (IV) over 30 seconds

B  0.2 mg (2 mL) IV over 60 seconds

C  0.5 mg (5 mL) IV over 30 seconds

D  0.2 mg (2 mL) IV over 15 seconds

A  “I often feel dizzy and lightheaded.”

B  “I feel like I breathe too deeply.”

C  “Nowadays I sleep for long hours.”

D  “I sleep less than I used to.”

A  Zaleplon

B  Eszopiclone

C  Ramelteon

D  Alprazolam

A  0.2 mg (2 mL) of flumazenil was given intravenously (IV).

B  The half-life of flumazenil is short.

C  Alcohol was consumed with the benzodiazepines.

D  A high dose of flumazenil was given.

A  Muscle spasms

B  Indicators of infection

C  Level of consciousness

D  Amount of bleeding

A  Antidote preparation

B  Seizure precautions

C  Airway maintenance

D  Comfort measures

A  Monitoring for suicidal tendencies

B  Assessing the patient’s risk for injury or falls

C  Monitoring the patient’s renal and hepatic function

D  Encouraging the patient to drink more fluids

A  Baclofen

B  Pentobarbital

C  Zaleplon

D  Diazepam

A  Eszopiclone

B  Temazepam

C  Clonazepam

D  Alprazolam

A  Liver dysfunction

B  Bronchial asthma

C  Narrow-angle glaucoma

D  Kidney dysfunction

A  Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

B  Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

C  Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

D  Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

A  Drinks grapefruit juice along with diazepam

B  Takes olanzapine along with diazepam

C  Takes phenobarbital along with diazepam

D  Takes rifampin along with diazepam

A  “Allow at least 8 hours for sleep.”

B  “Expect and prepare for a daytime hangover.”

C  “Report palpitations to the primary health care provider.”

D  “Take the medication with food or milk.”

A  Hypotension, Status epilepticus, Pregnancy

B  Pregnancy, Drug allergy, Significant respiratory difficulties

C  Hypotension, Drug allergy, Status epilepticus

D  Significant respiratory difficulties, Hypotension, Status epilepticus

A  Thiopental

B  Pentobarbital

C  Butabarbital

D  Phenobarbital

A  Produces drowsiness, lethargy, and blurred vision

B  Causes gastrointestinal distress

C  Impairs coordinated movements

D  Increases pain associated with activities

A  Drink coffee or tea in the morning.

B  Take the drug 30 minutes before sleeping.

C  Avoid using this drug to induce sleep.

D  Use the lowest effective dosage.

A  Respiratory arrest

B  Tonic-clonic seizure

C  Delirium tremens

D  Malignant hyperthermia

A  Recommend discussing an alternative drug for seizures with the primary health care provider.

B  Instruct the patient to increase the dosage of the contraceptive drug.

C  Suggest an alternate contraceptive method to the patient.

D  Request a prescription to increase the dosage of pentobarbital.

A  “I should avoid exercise just before going to bed.”

B  “I may be prescribed benzodiazepines to promote sleep.”

C  “I will stop drinking coffee at least 6 hours before bedtime.”

D  “I will have a glass of warm milk before bed.”

A  Administration of activated charcoal

B  Maintenance of an adequate airway

C  Administration of intravenous fluids

D  Administration of furosemide

A  Diazepam, Midazolam, Eszopiclone

B  Zolpidem, Ramelteon, Eszopiclone

C  Zolpidem, Diazepam, Midazolam

D  Diazepam, Ramelteon, Midazolam

A  Go to acupuncture therapy.

B  Drink lactose-free milk at bedtime.

C  Use home remedies of vegetables and herbs.

D  Take lower doses of benzodiazepines.

A  Infusion that is too rapid

B  Intravenous infiltration

C  Infusion without dilution

D  Infusion of other drugs

A  The therapeutic activity of temazepam is reduced with sleep.

B  Temazepam may cause gastrointestinal upset.

C  Temazepam induces sleep in approximately 1 hour.

D  Temazepam causes early awakening after sleep.

A  Duration of action on the central nervous system (CNS)

B  Degree of inhibition of nerve impulse transmission to the CNS

C  Dose of the drug used to produce the effect on the CNS

D  Degree of patient responsiveness to the drug given

A  Activated charcoal

B  Ipecac syrup

C  Naloxone

D  Flumazenil

A  Hallucinations

B  Dyspnea

C  Alertness

D  Ataxia

A  Temazepam

B  Midazolam

C  Flurazepam

D  Diazepam

A  Sleeping more during the day

B  Establishing a set sleep pattern

C  Avoiding tobacco at bedtime

D  Avoiding alcohol at bedtime

A  Diazepam

B  Ramelteon

C  Pentobarbital

D  Zaleplon

A  The patient is experiencing a muscle-relaxant overdose.

B  The patient is experiencing a barbiturate overdose.

C  The patient is experiencing benzodiazepine toxicity.

D  The patient was administered azole along with benzodiazepine.

A  Phenylephrine at a maximum dose of 2 mg

B  Flumazenil at a maximum dose of 3 mg

C  Flumazenil at a maximum dose of 1 mg

D  Phenylephrine at a maximum dose of 5 mg

A  Encouraging the patient to maintain a well-balanced diet

B  Teaching the patient about meditation

C  Instructing the patient to take low doses of benzodiazepines

D  Recommending that the patient consume a glass of warm lactose-free milk at bedtime

A  Amnesic properties

B  Inhibition of nerve impulse transmission

C  Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

D  Suppression of gamma-aminobutyric acid (GABA) receptors

A  Flumazenil

B  Olanzapine

C  Activated charcoal

D  Furosemide

A  Decreased benzodiazepine effects

B  Prolonged benzodiazepine action

C  Increased daytime sleepiness

D  Increased central nervous system (CNS) depression

A  Pentobarbital

B  Mephobarbital

C  Phenobarbital

D  Butabarbital

A  Oxytocin

B  Ceftriaxone

C  Phenobarbital

D  Sulfamethoxazole

A  The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

B  The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

C  The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

D  The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

A  Olanzapine

B  Verapamil

C  Rifampin

D  Flumazenil

A  Dry mouth

B  Decreased heart rate

C  Amnesia

D  Constipation

A  Baclofen

B  Diazepam

C  Dantrolene

D  Cyclobenzaprine

A  Midazolam

B  Alprazolam

C  Ramelteon

D  Eszopiclone

A  Increased perspiration

B  Increased body weight

C  Sleepwalking

D  Bedwetting

A  Prevention of lightheadedness

B  Relief of nerve pain

C  Reduction of choreiform movement

D  Reduction of muscle rigidity

A  Narrow-angle glaucoma

B  Epileptic disease

C  Drug allergy

D  Cardiac disease

A  Long-acting barbiturates

B  Short-acting barbiturates

C  Ultra-short-acting barbiturates

D  Intermediate-acting barbiturates

A  Daytime fatigue

B  Bedwetting

C  Sleepwalking

D  Vivid dreams

A  Relaxation

B  Sleepwalking

C  Dozing

D  Deep sleep

A  Zaleplon

B  Eszopiclone

C  Zolpidem

D  Ramelteon

A  Administer a second dose.

B  Continue to monitor consciousness for 2 minutes.

C  Provide another prescribed medication.

D  Administer four doses at 15-second intervals.